The microbial metabolite imidazole propionate dysregulates bone homeostasis by inhibiting AMP-activated protein kinase (AMPK) signaling
Abstract Microbial metabolites provide numerous benefits to the human body but can also contribute to diseases such as obesity, diabetes, cancer, and bone disorders. However, the role of imidazole propionate (ImP), a histidine-derived metabolite produced by the intestinal microbiome, in bone metabol...
Saved in:
Main Authors: | Suk-Gyun Park, Jung-Woo Kim, Ju Han Song, Seung-Hee Kwon, Sin-Hye Oh, Xianyu Piao, Zhao Wang, Je-Hwang Ryu, Nacksung Kim, Ok-Su Kim, Jeong-Tae Koh |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-12-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-024-07316-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypothalamic AMPK as a Regulator of Energy Homeostasis
by: My Khanh Q. Huynh, et al.
Published: (2016-01-01) -
Kinetics of imidazole propionate from orally delivered histidine in mice and humans
by: Moritz V. Warmbrunn, et al.
Published: (2024-11-01) -
Microbially produced imidazole propionate impairs prostate cancer progression through PDZK1
by: Shengkai Jin, et al.
Published: (2025-01-01) -
Dysregulation of Mitochondrial Homeostasis in Cardiovascular Diseases
by: Ricky Patil, et al.
Published: (2025-01-01) -
Spatially heterogeneous lipid dysregulation in tuberculous meningitis
by: John Kim, et al.
Published: (2024-11-01)